Mainz Biomed N.V. (QUCY)
Mainz Biomed N.V. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Mainz Biomed N.V. (QUCY) is a Medical - Diagnostics & Research company based in DE with a market capitalization of $33.5M. Revenue declined 39.9% year-over-year and free cash flow was negative at -$12M. This page tracks QUCY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
DE · 26 employees · IPO Nov 5, 2021
Valuation
Valuation & price
$3.49 · as of May 17, 2026 · -2.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
5.54
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$33.5M
Market cap
-39.9%
Revenue growth (YoY)
72.6%
Gross margin
-$12M
Free cash flow (USD)
$1.7M
Net debt
519.4%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2025
Free cash flow by year
2021 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.21)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventProperty Purchase AgreementJul 1, 2026Filing
- 8-K eventAccounting Firm ChangeJun 26, 2026Filing
- 8-K eventIntellectual Property License AgreementJun 15, 2026Filing
- 8-K eventTermination of Sales AgreementJun 5, 2026Filing
- FinancingSecurities RegistrationJun 4, 2026Filing
- 8-K eventIntellectual Property License AmendmentJun 3, 2026Filing
- 8-K eventRegained Nasdaq ComplianceMay 28, 2026Filing
- 8-K eventBusiness UpdateMay 26, 2026Filing
- 8-K eventIntellectual Property License AgreementMay 18, 2026Filing
- Quarterly report10-Q FiledMay 15, 2026Filing
Questions
Frequently asked questions
What is Mainz Biomed N.V.'s market cap?
Mainz Biomed N.V. (QUCY) has a market capitalization of $33.5M.
What is QUCY's P/E ratio?
A meaningful P/E ratio is not available for QUCY — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is QUCY's price-to-book (P/B) ratio?
QUCY trades at 5.54 times book value per share.
When did Mainz Biomed N.V. last report earnings?
QUCY last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying QUCY stock?
SEC Form 4 filings show no open-market insider buys at Mainz Biomed N.V. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.